We present a method to discover interesting brain regions in [18F] fluorodeoxyglucose positron emission tomography (PET) scans, showing also the benefits when PET scans are in combined use with non-imaging variables. The discriminative brain regions facilitate a better understanding of Alzheimer's disease (AD) progression, and they can also be used for predicting conversion from mild cognitive impairment (MCI) to AD. A survival analysis(Cox regression) and infinite Gaussian mixture model (IGMM) are introduced to identify the informative brain regions, which can be further used to make a prediction of conversion (in two years) from MCI to AD using only the baseline PET scan. Further, the predictive accuracy can be enhanced when non-imag...
Background: Amyloid-β (Aβ) accumulation in brain of patients with suspected Alzheimer's disease (AD)...
The assessment of the degree of order of brainmetabolism bymeans of a statisticalmechanistic approac...
Abstract: The biomarker-based new diagnostic criteria have been proposed for Alzheimer's disease (AD...
Aim: The value of 18F-fluorodeoxyglucose (FDG) PET for the prognosis of conversion from mild cogniti...
AimThe value of 18F-fluorodeoxyglucose (FDG) PET for the prognosis of conversion from mild cognitive...
Predicting progression of mild cognitive impairment (MCI) to Alzheimer's disease (AD) is clinically ...
Predicting progression of mild cognitive impairment (MCI) to Alzheimer's disease (AD) is clinically ...
We present a method to discover discriminative brain metabolism patterns in [18F] fluorodeoxyglucose...
Predicting progression of mild cognitive impairment (MCI) to Alzheimer's disease (AD) is clinically ...
We present a method to discover discriminative brain metabolism patterns in [18F] fluorodeoxyglucose...
We present a method to discover discriminative brain metabolism patterns in [18F] fluoro-deoxyglucos...
The assessment of the degree of order of brain metabolism by means of a statistical mechanistic appr...
For patients with mild cognitive impairment (MCI), the likelihood of progression to probable Alzheim...
Multimodal medical data (e.g. MR and PET imaging, CSF measurements, clinical assessments) reflect di...
Purpose: Mild cognitive impairment (MCI) is a transitional pathological stage between normal ageing ...
Background: Amyloid-β (Aβ) accumulation in brain of patients with suspected Alzheimer's disease (AD)...
The assessment of the degree of order of brainmetabolism bymeans of a statisticalmechanistic approac...
Abstract: The biomarker-based new diagnostic criteria have been proposed for Alzheimer's disease (AD...
Aim: The value of 18F-fluorodeoxyglucose (FDG) PET for the prognosis of conversion from mild cogniti...
AimThe value of 18F-fluorodeoxyglucose (FDG) PET for the prognosis of conversion from mild cognitive...
Predicting progression of mild cognitive impairment (MCI) to Alzheimer's disease (AD) is clinically ...
Predicting progression of mild cognitive impairment (MCI) to Alzheimer's disease (AD) is clinically ...
We present a method to discover discriminative brain metabolism patterns in [18F] fluorodeoxyglucose...
Predicting progression of mild cognitive impairment (MCI) to Alzheimer's disease (AD) is clinically ...
We present a method to discover discriminative brain metabolism patterns in [18F] fluorodeoxyglucose...
We present a method to discover discriminative brain metabolism patterns in [18F] fluoro-deoxyglucos...
The assessment of the degree of order of brain metabolism by means of a statistical mechanistic appr...
For patients with mild cognitive impairment (MCI), the likelihood of progression to probable Alzheim...
Multimodal medical data (e.g. MR and PET imaging, CSF measurements, clinical assessments) reflect di...
Purpose: Mild cognitive impairment (MCI) is a transitional pathological stage between normal ageing ...
Background: Amyloid-β (Aβ) accumulation in brain of patients with suspected Alzheimer's disease (AD)...
The assessment of the degree of order of brainmetabolism bymeans of a statisticalmechanistic approac...
Abstract: The biomarker-based new diagnostic criteria have been proposed for Alzheimer's disease (AD...